As companies roll out the pink beer in October to raise awareness of the disease, one group is urging young women to think twice.
A British company is seeding genetically modified flies with human tumors, giving patients their own personal drug trials.
Your takeout may come with a dose of chemicals known as PFAS—but the FDA’s push to get rid of some of them will take five years.
PrEP, or pre-exposure prophylaxis, pills are highly effective in blocking HIV if taken daily. But their drug trials have a mixed track record for access.
Researchers want to know if we can create an antiviral infrastructure that would protect humans from transmission. Here are a few ideas.
The federal agency cites concerns that the widely-used antacid may contain a possibly cancer-causing contaminant called NDMA.
They’ve created registries of people with chronic diseases who also have the new coronavirus, in order to track symptoms and find solutions.
Whole genome tests can help identify the cause of a baby’s mysterious illness. But ethicists say it’s still too soon to use them for all infants.